Equities
  • Price (EUR)1.52
  • Today's Change0.01 / 0.66%
  • Shares traded0.00
  • 1 Year change-14.61%
  • Beta1.3242
Data delayed at least 15 minutes, as of Feb 16 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Hygeia Healthcare Holdings Co Ltd is an investment holding company primarily engaged in the provision of medical services. The Company operates its businesses through two business segments. The Hospital Business segment provides one-stop comprehensive oncology diagnosis and treatment services, and carries out multi-disciplinary medical services centered around the core oncology business, including providing various oncology healthcare services including radiotherapy, chemotherapy, surgery, and targeted therapy, and gradually cover cancer diagnosis, treatment, and rehabilitation. The Other Business segment is mainly engaged in other businesses. The Company mainly conducts its businesses within domestic market.

  • Revenue in HKD (TTM)4.59bn
  • Net income in HKD521.85m
  • Incorporated2018
  • Employees8.02k
  • Location
    Hygeia Healthcare Holdings Co LtdUnit 1605/1606, Building 1, Fuyuan ZhidiSquare, 38 Yuanshen Road, Pudong New AreSHANGHAI ChinaCHN
  • Websitehttps://www.hygeia-group.com.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.